Intravenous proton pump inhibition utilization and prescribing patterns escalation: a comparison between early and current trends in use

Gastrointestinal Endoscopy

Volumn 69, Issue 1, 2009, Pages 3-9

  Law, Joanna K ^a   Andrews, Chris N ^a   Enns, Robert ^a  

^a ST PAUL S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PANTOPRAZOLE; PROTON PUMP INHIBITOR;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL ENDOSCOPY; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; RISK FACTOR; UPPER GASTROINTESTINAL BLEEDING;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; AGED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG UTILIZATION; ESOPHAGITIS, PEPTIC; ESOPHAGOSCOPY; FEMALE; FOLLOW-UP STUDIES; FORECASTING; GASTROESOPHAGEAL REFLUX; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PREMEDICATION; PRESCRIPTIONS; PROBABILITY; PROTON PUMPS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 58049204464     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gie.2008.04.053     Document Type: Article

References (32)

1. Trepanier E.F. Intravenous pantoprazole: a new tool for acutely ill patients who require acid suppression. [review]. Can J Gastroenterol 14 D Suppl (2000) 11-20D
2. Barkun A., Sabbah S., Enns R., et al. The Canadian Registry on Nonvariceal Upper Gastrointestinal Bleeding and Endoscopy (RUGBE): endoscopic hemostasis and proton pump inhibition are associated with improved outcomes in a real-life setting. Am J Gastroenterol 99 (2004) 1238-1246
3. Barkun A.N., Cockeram A.W., Plourde V., et al. Review article: acid suppression in non-variceal acute upper gastrointestinal bleeding. [review]. Aliment Pharmacol Ther 13 (1999) 1565-1584
4. Daneshmend T.K., Hawkey C.J., Langman M.J., et al. Omeprazole versus placebo for acute upper gastrointestinal bleeding: randomised double blind controlled trial. [comment]. BMJ 304 (1992) 143-147
5. Gisbert J.P., Gonzalez L., Calvet X., et al. Proton pump inhibitors versus H2-antagonists: a meta-analysis of their efficacy in treating bleeding peptic ulcer. Aliment Pharmacol Ther 15 (2001) 917-6
6. Hasselgren G., Lind T., Lundell L., et al. Continuous intravenous infusion of omeprazole in elderly patients with peptic ulcer bleeding: results of a placebo-controlled multicenter study. Scand J Gastroenterol 32 (1997) 328-333
7. Javid G., Masoodi I., Zargar S.A., et al. Omeprazole as adjuvant therapy to endoscopic combination injection sclerotherapy for treating bleeding peptic ulcer. Am J Med 111 (2001) 280-284
8. Lau J.Y., and Chung S. Management of upper gastrointestinal haemorrhage. [review]. J Gastroenterol Hepatol 15 Suppl (2000) G8-G12
9. Lin H.J., Lo W.C., Lee F.Y., et al. A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy. Arch Intern Med 158 (1998) 54-58
10. Schaffalitzky de Muckadell O.B., Havelund T., Harling H., et al. Effect of omeprazole on the outcome of endoscopically treated bleeding peptic ulcers: randomized double-blind placebo-controlled multicentre study. Scand J Gastroenterol 32 (1997) 320-327
11. Spiegel B., Ofman J., Woods K., et al. Minimizing recurrent peptic ulcer hemorrhage after endoscopic hemostasis: the cost effectiveness of competing strategies. Am J Gastroenterol 98 (2003) 86-97
12. Villanueva C., Balanzo J., Torras X., et al. Omeprazole versus ranitidine as adjunct therapy to endoscopic injection in actively bleeding ulcers: a prospective and randomized study. Endoscopy 27 (1995) 308-312
13. Yacyshyn B.R., and Thomson A.B. Critical review of acid suppression in nonvariceal, acute, uppergastrointestinal bleeding. [review]. Dig Dis 18 (2000) 117-128
14. Zed P.J., Loewen P.S., Slavik R.S., et al. Meta-analysis of proton pump inhibitors in treatment of bleeding peptic ulcers. Ann Pharmacother 35 (2001) 1528-1534
15. Barkun A., Bardou M., Marshall J.K., et al. Consensus recommendations for managing patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med 139 (2003) 843-857
16. Lau J.Y., Sung J.J., Lee K.K., et al. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med 343 (2000) 310-316
17. Lau J.Y., Leung W.K., and Wu J.C. Omeprazole before endoscopy in patients with gastrointestinal bleeding. N Engl J Med 356 (2007) 1631-1640
18. Green Jr. F.W., Kaplan M.M., Curtis L.E., et al. Effect of acid and pepsin on blood coagulation and platelet aggregation: a possible contributor prolonged gastroduodenal mucosal hemorrhage. Gastroenterology 74 (1978) 38-43
19. Hasselgren G., Keelan M., Kirdeikis P., et al. Optimization of acid suppression for patients with peptic ulcer bleeding: an intragastric pH-metry study with omeprazole. Eur J Gastroenterol Hepatol 10 (1998) 601-606
20. Patchett S.E., Enright H., Afdhal N., et al. Clot lysis by gastric juice: an in vitro study. Gut 30 (1989) 1704-1707
21. Patchett S.E., and O'Donoghue D.P. Pharmacological manipulation of gastric juice: thrombelastographic assessment and implications for treatment of gastrointestinal haemorrhage. Gut 36 (1995) 358-362
22. Tseng G.Y., Lin H.J., Lin H.Y., et al. The influence of intravenous omeprazole on intragastric pH and outcomes in patients with peptic ulcer bleeding after successful endoscopic therapy-a prospective randomized comparative trial. Hepatogastroenterology 46 (1999) 2183-2188
23. Walt R.P., Reynolds J.R., Langman M.J., et al. Intravenous omeprazole rapidly raises intragastric pH. Gut 26 (1985) 902-906
24. Berstad A. Does profound acid inhibition improve haemostasis in peptic ulcer bleeding?. Scand J Gastroenterol 32 (1997) 396-398
25. Panto IV. Wyeth Pharmaceuticals. May 2008. Available at: www.wyeth.com. Accessed June 10, 2008.
26. Protonix. Wyeth Pharmaceuticals. December 2007. Available at: www.wyeth.com. Accessed June 10, 2008.
27. Lau J.Y., Sung J.J., Lee K.K., et al. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med 343 (2000) 310-316
28. Charlson M.E., Pompei P., Ales K.I., et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 40 (1987) 373-383
29. Enns R., Andrews C.N., Fishman M., et al. Description of prescribing practices in patients with upper gastrointestinal bleeding receiving intravenous proton pump inhibitors: a multicentre evaluation. Can J Gastroenterol 18 (2004) 567-571
30. Andrews C.N., Levy A., Fishman M., et al. Intravenous proton pump inhibitors before endoscopy in bleeding peptic ulcer with high risk stigmata: a multicentre comparative study. Can J Gastroenterol 19 (2005) 667-671
31. Enns R.A., Gagnon Y.M., Rioux K.P., et al. Cost-effectiveness in Canada of intravenous proton pump inhibitors for all patients presenting with acute upper gastrointestinal bleeding. Aliment Pharmacol Ther 17 (2003) 225-233
32. Gagnon Y.M., Levy A.R., Eloubeidi M.A., et al. Cost implications of administering intravenous proton pump inhibitors to all patients presenting to the emergency department with peptic ulcer bleeding. Value Health 6 (2003) 457-465